Data / Drug companies / Novel Laboratories, Inc.
Novel Laboratories, Inc.: 22 products in the FDA NDC directory, labeler code 40032
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Novel Laboratories, Inc. (labeler code 40032) lists 22 products in the FDA National Drug Code Directory, covering 17 finished drugs by generic name. By type: 22 prescription drugs. Its main marketing category is generic drugs (ANDA). The newest product started marketing on November 21, 2018.
The request: Watch Novel Laboratories, Inc. (FDA labeler code 40032): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 40032
- Products in commercial distribution
- 22
- Packages
- 42
- Finished drugs by generic name
- 17
- Prescription products
- 22
- Over the counter products
- 0
- Controlled substance products
- Schedule II 3
- Flagged as original packager
- 22 of 22 products that carry the flag
- Started marketing in the last 12 months
- 0
- Earliest marketing start
- June 1, 2009
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 22 | 100% |
Products by type
| Type | Products | Share |
|---|---|---|
| Prescription drugs | 22 | 100% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 7 | 31.8% |
| Solution | 4 | 18.2% |
| Capsule | 4 | 18.2% |
| Suspension | 2 | 9.1% |
| Ointment | 2 | 9.1% |
| For solution | 1 | 4.5% |
| Powder, for solution | 1 | 4.5% |
| Syrup | 1 | 4.5% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Potassium Chloride | 40032-194 | For solution | Generic drugs (ANDA) | November 21, 2018 |
| Carbidopa | 40032-980 | Tablet | Generic drugs (ANDA) | October 20, 2017 |
| Doxycycline Hyclate | 40032-794 | Tablet | Generic drugs (ANDA) | September 6, 2017 |
| Fluocinonide | 40032-026 | Solution | Generic drugs (ANDA) | July 21, 2017 |
| Flucytosine | 40032-771 | Capsule | Generic drugs (ANDA) | July 7, 2017 |
| Flucytosine | 40032-770 | Capsule | Generic drugs (ANDA) | July 7, 2017 |
| Sodium sulfate, potassium sulfate, magnesium sulfate | 40032-700 | Solution | Generic drugs (ANDA) | February 23, 2017 |
| Hydrocodone Bitartrate and Homatropine Methylbromide | 40032-810 | Syrup | Generic drugs (ANDA) | February 13, 2017 |
| Cevimeline hydrochloride | 40032-999 | Capsule | Generic drugs (ANDA) | December 30, 2016 |
| Clobetasol propionate | 40032-096 | Ointment | Generic drugs (ANDA) | November 25, 2016 |
| Voriconazole | 40032-038 | Suspension | Generic drugs (ANDA) | June 1, 2016 |
| Desoximetasone | 40032-024 | Ointment | Generic drugs (ANDA) | May 10, 2016 |
| Diclofenac sodium | 40032-016 | Solution | Generic drugs (ANDA) | December 9, 2015 |
| Clobetasol propionate | 40032-028 | Solution | Generic drugs (ANDA) | November 23, 2015 |
| Oxycodone Hydrochloride | 40032-950 | Capsule | Generic drugs (ANDA) | August 24, 2015 |
| Hydrocodone Bitartrate and Homatropine Methylbromide | 40032-118 | Tablet | Generic drugs (ANDA) | September 23, 2014 |
| Nitrofurantoin | 40032-450 | Suspension | Generic drugs (ANDA) | September 8, 2014 |
| Trimethoprim | 40032-330 | Tablet | Generic drugs (ANDA) | March 4, 2014 |
| Levonorgestrel | 40032-622 | Tablet | Generic drugs (ANDA) | February 15, 2013 |
| Misoprostol | 40032-161 | Tablet | Generic drugs (ANDA) | July 25, 2012 |
| Misoprostol | 40032-160 | Tablet | Generic drugs (ANDA) | July 25, 2012 |
| Polyethylene glycol-3350 and electrolytes | 40032-090 | Powder, for solution | Generic drugs (ANDA) | June 1, 2009 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.